PT-141 side effects and results in studies
Where a cited study reported on tolerability, its wording is carried over unchanged below. Human work of this size does not establish a safety profile.
Adverse events reported
| Event | As reported | Source |
|---|---|---|
| The most common adverse events versus placebo were nausea (40. | Human | Clayton AH et al. |
| Adverse events were nausea, flushing and headache. | Human | Clayton AH et al. |
| Drug-related adverse effects were more frequent with bremelanotide. | Human | Safarinejad MR et al. |
| PT-141 was well tolerated in both studies. | Human | Rosen RC et al. |
| The combination did not bring new or more frequent adverse events. | Human | Diamond LE et al. |
Outcomes measured
No outcome data are tabulated yet.
What the studies don't show
Nothing here speaks to use outside the trial protocol. Testing establishes identity and purity; it is not evidence of an effect.